# Sex differences in abnormal gluten response and predictors of gluten sensitivity in patients with schizophrenia

## TL;DR

This study finds that men with schizophrenia show stronger immune responses to gluten than women, highlighting sex differences in immune and gut-related factors.

## Contribution

The first study to examine sex-related differences in gluten immune responses among schizophrenia patients.

## Key findings

- Men with schizophrenia had higher IgG levels against gluten compared to women.
- Factors like tTG IgA, hs-CRP, and age predicted AGA IgA positivity in schizophrenia patients.
- AGA IgG positivity was linked to dGP, ASCA antibodies, and negative symptoms in SZ patients.

## Abstract

Immune-inflammatory dysregulations are linked to shifts in specific gut microbiota genera, underscoring the importance of the gut–brain connection in schizophrenia (SZ). However, the immune-inflammatory aspects of sex differences in SZ remain largely unexplored. The aims of this study were (1) to identify sex-related differences in inflammatory response, intestinal biomarkers, and gluten sensitivity in SZ and (2) to determine potential factors underlying variability in the immune response to gluten in this population.

A total of 102 individuals with SZ and 60 healthy controls (HC) were included in the study.

Elevated titers of anti-gliadin (AGA) IgA were found in 26% of individuals with SZ compared to 22% of HC and elevated AGA IgG in 30% of SZ patients compared to 20% of HC. The IgG levels were higher in men than in women, regardless of health status. Significant differences in the levels of AGA IgG and deamidated gliadin (dGP) IgG were observed between men and women with SZ, with higher concentrations detected in men. Factors differentiating patients with positive AGA IgA antibodies included tissue transglutaminase (tTG) IgA levels, high-sensitivity C-reactive protein (hs-CRP) levels, and age. Factors associated with positive AGA IgG antibodies included dGP and anti-Saccharomyces cerevisiae (ASCA) antibody levels, negative symptoms of SZ, and age of onset.

This is the first study to examine sex-related differences and illness stage in the immune response to gluten among SZ patients. Stronger inflammatory responses were found in men, suggesting sex-related disparities in gluten-related immune activation. These findings highlight a complex interplay between hormones, immune function, intestinal barrier integrity, and psychiatric symptoms. Further longitudinal research is needed to clarify these mechanisms and their clinical significance.